Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease

被引:7
|
作者
Rivero, Jesus [1 ]
Rodriguez, Francisco [2 ]
Soto, Virgilia [2 ]
Macedo, Etienne [3 ]
Chawla, Lakhmir S. [3 ]
Mehta, Ravindra L. [3 ]
Vaingankar, Sucheta [2 ]
Garimella, Pranav S. [3 ]
Garza, Carlos [2 ]
Madero, Magdalena [2 ]
机构
[1] Natl Inst Lung Dis Ismael Cosio Villegas, Nephrol Dept, Mexico City, DF, Mexico
[2] Natl Inst Cardiol Ignacio Chavez, Nephrol Dept, Juan Badiano 1, Mexico City 14080, DF, Mexico
[3] Univ Calif San Diego, Div Nephrol, San Diego, CA 92103 USA
关键词
Interstitial fibrosis; Uresis; Kidney biopsy; Furosemide stress test; SERUM CREATININE; DIFFERENTIAL-DIAGNOSIS; COCKCROFT-GAULT; TUBULAR ATROPHY; RENAL-FUNCTION; MARKERS; CLEARANCE; MECHANISMS; PREDICTION; EQUATIONS;
D O I
10.1186/s12882-020-01721-z
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Interstitial fibrosis (IF) on kidney biopsy is one of the most potent risk factors for kidney disease progression. The furosemide stress test (FST) is a validated tool that predicts the severity of acute kidney injury (especially at 2 h) in critically ill patients. Since furosemide is secreted through the kidney tubules, the response to FST represents the tubular secretory capacity. To our knowledge there is no data on the correlation between functional tubular capacity assessed by the FST with IF on kidney biopsies from patients with chronic kidney disease (CKD). The aim of this study was to determine the association between urine output (UO), Furosemide Excreted Mass (FEM) and IF on kidney biopsies after a FST. Methods This study included 84 patients who underwent kidney biopsy for clinical indications and a FST. The percentage of fibrosis was determined by morphometry technique and reviewed by a nephropathologist. All patients underwent a FST prior to the biopsy. Urine volume and urinary sodium were measured in addition to urine concentrations of furosemide at different times (2, 4 and 6 h). We used an established equation to determine the FEM. Values were expressed as mean, standard deviation or percentage and Pearson Correlation. Results The mean age of the participants was 38 years and 44% were male. The prevalence of diabetes mellitus, hypertension and diuretic use was significantly higher with more advanced degree of fibrosis. Nephrotic syndrome and acute kidney graft dysfunction were the most frequent indications for biopsy. eGFR was inversely related to the degree of fibrosis. Subjects with the highest degree of fibrosis (grade 3) showed a significant lower UO at first hour of the FST when compared to lower degrees of fibrosis (p = 0.015). Likewise, the total UO and the FEM was progressively lower with higher degrees of fibrosis. An inversely linear correlation between FEM and the degree of fibrosis (r = - 0.245, p = 0.02) was observed. Conclusions Our findings indicate that interstitial fibrosis correlates with total urine output and FEM. Further studies are needed to determine if UO and FST could be a non-invasive tool to evaluate interstitial fibrosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease
    Jesús Rivero
    Francisco Rodríguez
    Virgilia Soto
    Etienne Macedo
    Lakhmir S. Chawla
    Ravindra L. Mehta
    Sucheta Vaingankar
    Pranav S. Garimella
    Carlos Garza
    Magdalena Madero
    BMC Nephrology, 21
  • [2] Furosemide test in stage III-chronic kidney disease and kidney transplant patients on tacrolimus
    Carlos G. Musso
    Matilde Navarro
    Cesar Mombelli
    Cora Giordani
    Roxana Groppa
    B. Martinez
    Raul De Miguel
    Nora Imperiali
    International Urology and Nephrology, 2013, 45 : 1471 - 1474
  • [3] Furosemide test in stage III-chronic kidney disease and kidney transplant patients on tacrolimus
    Musso, Carlos G.
    Navarro, Matilde
    Mombelli, Cesar
    Giordani, Cora
    Groppa, Roxana
    Martinez, B.
    De Miguel, Raul
    Imperiali, Nora
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (05) : 1471 - 1474
  • [4] Obesity, oxidative stress, and fibrosis in chronic kidney disease
    Sharma, Kumar
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2014, 4 (01) : 113 - 117
  • [6] Diffuse Interstitial Fibrosis and Myocardial Dysfunction in Early Chronic Kidney Disease
    Edwards, Nicola C.
    Moody, William E.
    Yuan, Mengshi
    Hayer, Manvir K.
    Ferro, Charles J.
    Townend, Jonathan N.
    Steeds, Richard P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (09): : 1311 - 1317
  • [7] Diffuse Myocardial Interstitial Fibrosis and Dysfunction in Early Chronic Kidney Disease
    Hayer, Manvir Kaur
    Price, Anna Marie
    Liu, Boyang
    Baig, Shanat
    Ferro, Charles Joseph
    Townend, Jonathan Nicholas
    Steeds, Richard Paul
    Edwards, Nicola Catherine
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (05): : 656 - 660
  • [8] Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease
    Nakagawa, Shunsaku
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2017, 137 (11): : 1355 - 1360
  • [9] Nox and chronic kidney allograft interstitial fibrosis
    Reese, Shannon
    Adulla, Madhu
    Bedi, Surmeet
    Torrealba, Jose
    Hullett, Deb
    Djamali, Arjang
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 208 - 209
  • [10] Progression of chronic kidney disease in children - role of glomerular hemodynamics and interstitial fibrosis
    Oliveira, Eduardo A.
    Mak, Robert H.
    CURRENT OPINION IN PEDIATRICS, 2018, 30 (02) : 220 - 227